134 related articles for article (PubMed ID: 37341553)
1. SARS-CoV-2 intrahost evolution in immunocompromised patients in comparison with immunocompetent populations after treatment.
Ahmadi AS; Zadheidar S; Sadeghi K; Nejati A; Salimi V; Hajiabdolbaghi M; Mokhtari-Azad T; Yavarian J
J Med Virol; 2023 Jun; 95(6):e28877. PubMed ID: 37341553
[TBL] [Abstract][Full Text] [Related]
2. Coronavirus Genomes and Unique Mutations in Structural and Non-Structural Proteins in Pakistani SARS-CoV-2 Delta Variants during the Fourth Wave of the Pandemic.
Anwar MZ; Lodhi MS; Khan MT; Khan MI; Sharif S
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328105
[TBL] [Abstract][Full Text] [Related]
3. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.
Patro LPP; Sathyaseelan C; Uttamrao PP; Rathinavelan T
Infect Genet Evol; 2021 Sep; 93():104973. PubMed ID: 34147651
[TBL] [Abstract][Full Text] [Related]
4. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
Bui NN; Lin YT; Huang SH; Lin CW
Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
[TBL] [Abstract][Full Text] [Related]
5. Genomic characterization unravelling the causative role of SARS-CoV-2 Delta variant of lineage B.1.617.2 in 2nd wave of COVID-19 pandemic in Chhattisgarh, India.
Singh P; Sharma K; Singh P; Bhargava A; Negi SS; Sharma P; Bhise M; Tripathi MK; Jindal A; Nagarkar NM
Microb Pathog; 2022 Mar; 164():105404. PubMed ID: 35065253
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Quasispecies Provides an Advantage Mutation Pool for the Epidemic Variants.
Sun F; Wang X; Tan S; Dan Y; Lu Y; Zhang J; Xu J; Tan Z; Xiang X; Zhou Y; He W; Wan X; Zhang W; Chen Y; Tan W; Deng G
Microbiol Spectr; 2021 Sep; 9(1):e0026121. PubMed ID: 34346744
[TBL] [Abstract][Full Text] [Related]
7. Genome sequence diversity of SARS-CoV-2 obtained from clinical samples in Uzbekistan.
Abdullaev A; Abdurakhimov A; Mirakbarova Z; Ibragimova S; Tsoy V; Nuriddinov S; Dalimova D; Turdikulova S; Abdurakhmonov I
PLoS One; 2022; 17(6):e0270314. PubMed ID: 35759503
[TBL] [Abstract][Full Text] [Related]
8. Surveillance and Molecular Characterization of SARS-CoV-2 Infection in Non-Human Hosts in Gujarat, India.
Kumar D; Antiya SP; Patel SS; Pandit R; Joshi M; Mishra AK; Joshi CG; Patel AC
Int J Environ Res Public Health; 2022 Nov; 19(21):. PubMed ID: 36361271
[TBL] [Abstract][Full Text] [Related]
9. Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment.
Chen L; Zody MC; Di Germanio C; Martinelli R; Mediavilla JR; Cunningham MH; Composto K; Chow KF; Kordalewska M; Corvelo A; Oschwald DM; Fennessey S; Zetkulic M; Dar S; Kramer Y; Mathema B; Germer S; Stone M; Simmons G; Busch MP; Maniatis T; Perlin DS; Kreiswirth BN
mSphere; 2021 Aug; 6(4):e0048021. PubMed ID: 34431691
[TBL] [Abstract][Full Text] [Related]
10. Emergence of SARS-CoV-2 Spike Mutations during Prolonged Infection in Immunocompromised Hosts.
Ko KKK; Yingtaweesittikul H; Tan TT; Wijaya L; Cao DY; Goh SS; Abdul Rahman NB; Chan KXL; Tay HM; Sim JHC; Chan KS; Oon LLE; Nagarajan N; Suphavilai C
Microbiol Spectr; 2022 Jun; 10(3):e0079122. PubMed ID: 35543562
[TBL] [Abstract][Full Text] [Related]
11. High diversity in Delta variant across countries revealed by genome-wide analysis of SARS-CoV-2 beyond the Spike protein.
Suratekar R; Ghosh P; Niesen MJM; Donadio G; Anand P; Soundararajan V; Venkatakrishnan AJ
Mol Syst Biol; 2022 Feb; 18(2):e10673. PubMed ID: 35156767
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 shedding dynamics and transmission in immunosuppressed patients.
Lee JS; Yun KW; Jeong H; Kim B; Kim MJ; Park JH; Shin HS; Oh HS; Sung H; Song MG; Cho SI; Kim SY; Kang CK; Choe PG; Park WB; Kim NJ; Oh MD; Choi EH; Park S; Kim TS; Lee JH; Sung H; Park SS; Seong MW
Virulence; 2022 Dec; 13(1):1242-1251. PubMed ID: 35891618
[TBL] [Abstract][Full Text] [Related]
13. Geographical distribution of SARS-CoV-2 amino acids mutations and the concomitant evolution of seven distinct clades in non-human hosts.
Magateshvaren Saras MA; Patro LPP; Uttamrao PP; Rathinavelan T
Zoonoses Public Health; 2022 Nov; 69(7):816-825. PubMed ID: 35614572
[TBL] [Abstract][Full Text] [Related]
14. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
Bui NN; Lin YT; Huang SH; Lin CW
Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
[TBL] [Abstract][Full Text] [Related]
15. Highly Divergent SARS-CoV-2 Alpha Variant in Chronically Infected Immunocompromised Person.
Munnink BBO; Nijhuis RHT; Worp N; Boter M; Weller B; Verstrepen BE; GeurtsvanKessel C; Corsten MF; Russcher A; Koopmans M
Emerg Infect Dis; 2022 Sep; 28(9):1920-1923. PubMed ID: 35925013
[TBL] [Abstract][Full Text] [Related]
16. Identification of a High-Frequency Intrahost SARS-CoV-2 Spike Variant with Enhanced Cytopathic and Fusogenic Effects.
Rocheleau L; Laroche G; Fu K; Stewart CM; Mohamud AO; Côté M; Giguère PM; Langlois MA; Pelchat M
mBio; 2021 Jun; 12(3):e0078821. PubMed ID: 34182784
[TBL] [Abstract][Full Text] [Related]
17. Cumulative SARS-CoV-2 mutations and corresponding changes in immunity in an immunocompromised patient indicate viral evolution within the host.
Sonnleitner ST; Prelog M; Sonnleitner S; Hinterbichler E; Halbfurter H; Kopecky DBC; Almanzar G; Koblmüller S; Sturmbauer C; Feist L; Horres R; Posch W; Walder G
Nat Commun; 2022 May; 13(1):2560. PubMed ID: 35538074
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 evolution during prolonged infection in immunocompromised patients.
Marques AD; Graham-Wooten J; Fitzgerald AS; Sobel Leonard A; Cook EJ; Everett JK; Rodino KG; Moncla LH; Kelly BJ; Collman RG; Bushman FD
mBio; 2024 Mar; 15(3):e0011024. PubMed ID: 38364100
[TBL] [Abstract][Full Text] [Related]
19. Emergence of SARS-CoV-2 variant of interest B.1.525 (Eta) in Bangladesh.
Goswami B; Sarkar MMH; Akter S; Banu TA; Jahan I; Hossain MS; Uddin MM; Nafisa T; Molla MMA; Yeasmin M; Osman E; Uzzaman MS; Mahmud ASM; Habib A; Khan S
Biologicals; 2023 Nov; 84():101714. PubMed ID: 37804694
[TBL] [Abstract][Full Text] [Related]
20. The dynamics of circulating SARS-CoV-2 lineages in Bogor and surrounding areas reflect variant shifting during the first and second waves of COVID-19 in Indonesia.
Prasetyoputri A; Dharmayanthi AB; Iryanto SB; Andriani A; Nuryana I; Wardiana A; Ridwanuloh AM; Swasthikawati S; Hariyatun H; Nugroho HA; Idris I; Indriawati I; Noviana Z; Oktavia L; Yuliawati Y; Masrukhin M; Hasrianda EF; Sukmarini L; Fahrurrozi F; Yanthi ND; Fathurahman AT; Wulandari AS; Setiawan R; Rizal S; Fathoni A; Kusharyoto W; Lisdiyanti P; Ningrum RA; Saputra S
PeerJ; 2022; 10():e13132. PubMed ID: 35341058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]